|Bid||0.0000 x 1000|
|Ask||0.0000 x 1200|
|Day's Range||4.7500 - 5.4800|
|52 Week Range||4.7500 - 21.0500|
|Beta (5Y Monthly)||1.72|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 04, 2023 - Dec 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.50|
Avid Bioservices (CDMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Aclaris (ACRS) decides to stop the development of its lead drug after top-line data from a mid-stage study did not achieve any study goals. Shares plunge 86% following the news.
Even the best stock pickers will make plenty of bad investments. And unfortunately for Avid Bioservices, Inc...